Sr. Director , Regulatory Affairs, Global Regulatory Lead - Development Strategy jobs in United States
cer-icon
Apply on Employer Site
company-logo

Insmed Incorporated · 3 days ago

Sr. Director , Regulatory Affairs, Global Regulatory Lead - Development Strategy

Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. The Global Regulatory Lead will be responsible for formulating and implementing global regulatory strategies to enable efficient product development, serving as the primary regulatory contact for the U.S. FDA and overseeing regulatory submissions and communications with global health authorities.

BiotechnologyMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Lead development and execution of global regulatory strategies for clinical, pre-clinical, and lifecycle management activities for assigned programs
Identify and assess regulatory risks associated with product development and define risk-mitigation strategies
Provide regulatory guidance across functions throughout the R&D process and advise on the US IND and global CTA submission strategies
Direct the planning and coordination of global regulatory submissions, including clinical trial applications for multinational trials, core briefing packages, and global marketing applications
Oversee the organization and preparation of clear, concise, and effective regulatory submissions
Provide oversight for preparation and delivery of materials for regulatory agency meetings
Prepare and deliver high-quality presentations for both internal and external audiences
Monitor, evaluate, and interpret global regulatory agency activities in relevant areas; assess potential impact on company programs
Lead effectively in a matrix environment, collaborating with regional regulatory leads and cross-functional teams

Qualification

Regulatory AffairsRegulatory submissionsGlobal regulatory requirementsSubmission writingDrug development processAttention to detailCollaborationPresentation skills

Required

Bachelor's degree in life sciences or a related field required
Minimum of 5 years of experience in Regulatory Affairs, with hands-on experience in regulatory submissions across multiple regions (U.S., EU, and/or other international markets)
Strong knowledge of global regulatory requirements and submission formats (eCTD)
Proven experience managing complex regulatory deliverables across product lifecycle stages
Strong submission writing and review skills essential
Significant experience in interactions with FDA, EMA, and other global regulatory agencies
Deep understanding of the drug development process
Highly organized with strong attention to detail, accuracy, clarity, and conciseness
Ability to manage tight deadlines; must be efficient, detail-oriented, adaptable, and a self-starter

Preferred

advanced degree (MS, PhD, PharmD) strongly preferred
Experience with orphan drug products is highly preferred
Experience with inhalation products a plus

Benefits

Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back

Company

Insmed Incorporated

twittertwittertwitter
company-logo
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.

Funding

Current Stage
Public Company
Total Funding
$4.56B
Key Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M

Leadership Team

leader-logo
Drayton Wise
Chief Commercial Officer
linkedin
Company data provided by crunchbase